---
document_datetime: 2025-12-02 06:24:13
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/clopidogrel-qualimed.html
document_name: clopidogrel-qualimed.html
version: success
processing_time: 0.0816637
conversion_datetime: 2025-12-29 21:28:12.909111
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Clopidogrel Qualimed

[RSS](/en/individual-human-medicine.xml/65936)

##### Withdrawn

This medicine's authorisation has been withdrawn

clopidogrel Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 23 September 2009, the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Clopidogrel Qualimed, generic of Plavix, which had been approved for adults patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

The marketing authorisation holder (MAH) responsible for Clopidogrel Qualimed was Qualimed. On 01 September 2014, the European Commission issued a decision to withdraw the marketing authorisation for Clopidogrel Qualimed, following its receipt of a letter dated 10 August 2014 notifying the Commission of the MAH's decision to voluntarily withdraw the marketing authorisation for this product for marketing reason. Clopidogrel Qualimed was not marketed in any European country.

Pursuant to this decision, the European public assessment report for Clopidogrel Qualimed is updated to reflect that the marketing authorisation is no longer valid.

Clopidogrel Qualimed : EPAR - Summary for the public

English (EN) (174.92 KB - PDF)

**First published:** 14/10/2009

**Last updated:** 08/09/2014

[View](/en/documents/overview/clopidogrel-qualimed-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-364)

български (BG) (323.08 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/bg/documents/overview/clopidogrel-qualimed-epar-summary-public_bg.pdf)

español (ES) (176.99 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/es/documents/overview/clopidogrel-qualimed-epar-summary-public_es.pdf)

čeština (CS) (301.32 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/cs/documents/overview/clopidogrel-qualimed-epar-summary-public_cs.pdf)

dansk (DA) (176.75 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/da/documents/overview/clopidogrel-qualimed-epar-summary-public_da.pdf)

Deutsch (DE) (177.6 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/de/documents/overview/clopidogrel-qualimed-epar-summary-public_de.pdf)

eesti keel (ET) (175.85 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/et/documents/overview/clopidogrel-qualimed-epar-summary-public_et.pdf)

ελληνικά (EL) (334.55 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/el/documents/overview/clopidogrel-qualimed-epar-summary-public_el.pdf)

français (FR) (177.4 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/fr/documents/overview/clopidogrel-qualimed-epar-summary-public_fr.pdf)

italiano (IT) (176.33 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/it/documents/overview/clopidogrel-qualimed-epar-summary-public_it.pdf)

latviešu valoda (LV) (299.36 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/lv/documents/overview/clopidogrel-qualimed-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (285.91 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/lt/documents/overview/clopidogrel-qualimed-epar-summary-public_lt.pdf)

magyar (HU) (292.15 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/hu/documents/overview/clopidogrel-qualimed-epar-summary-public_hu.pdf)

Malti (MT) (301.78 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/mt/documents/overview/clopidogrel-qualimed-epar-summary-public_mt.pdf)

Nederlands (NL) (176.64 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/nl/documents/overview/clopidogrel-qualimed-epar-summary-public_nl.pdf)

polski (PL) (306.59 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/pl/documents/overview/clopidogrel-qualimed-epar-summary-public_pl.pdf)

português (PT) (176.67 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/pt/documents/overview/clopidogrel-qualimed-epar-summary-public_pt.pdf)

română (RO) (280.12 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/ro/documents/overview/clopidogrel-qualimed-epar-summary-public_ro.pdf)

slovenčina (SK) (297.01 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/sk/documents/overview/clopidogrel-qualimed-epar-summary-public_sk.pdf)

slovenščina (SL) (255.96 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/sl/documents/overview/clopidogrel-qualimed-epar-summary-public_sl.pdf)

Suomi (FI) (176.12 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/fi/documents/overview/clopidogrel-qualimed-epar-summary-public_fi.pdf)

svenska (SV) (176.23 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/sv/documents/overview/clopidogrel-qualimed-epar-summary-public_sv.pdf)

## Product information

Clopidogrel Qualimed : EPAR - Product Information

English (EN) (451.46 KB - PDF)

**First published:** 14/10/2009

**Last updated:** 08/09/2014

[View](/en/documents/product-information/clopidogrel-qualimed-epar-product-information_en.pdf)

[Other languages (23)](#file-language-dropdown-287)

български (BG) (813.16 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/bg/documents/product-information/clopidogrel-qualimed-epar-product-information_bg.pdf)

español (ES) (469.37 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/es/documents/product-information/clopidogrel-qualimed-epar-product-information_es.pdf)

čeština (CS) (616.66 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/cs/documents/product-information/clopidogrel-qualimed-epar-product-information_cs.pdf)

dansk (DA) (454.34 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/da/documents/product-information/clopidogrel-qualimed-epar-product-information_da.pdf)

Deutsch (DE) (542.85 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/de/documents/product-information/clopidogrel-qualimed-epar-product-information_de.pdf)

eesti keel (ET) (448.74 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/et/documents/product-information/clopidogrel-qualimed-epar-product-information_et.pdf)

ελληνικά (EL) (858.82 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/el/documents/product-information/clopidogrel-qualimed-epar-product-information_el.pdf)

français (FR) (477.42 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/fr/documents/product-information/clopidogrel-qualimed-epar-product-information_fr.pdf)

íslenska (IS) (502.48 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/is/documents/product-information/clopidogrel-qualimed-epar-product-information_is.pdf)

italiano (IT) (473.65 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/it/documents/product-information/clopidogrel-qualimed-epar-product-information_it.pdf)

latviešu valoda (LV) (641.44 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/lv/documents/product-information/clopidogrel-qualimed-epar-product-information_lv.pdf)

lietuvių kalba (LT) (465.26 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/lt/documents/product-information/clopidogrel-qualimed-epar-product-information_lt.pdf)

magyar (HU) (632.28 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/hu/documents/product-information/clopidogrel-qualimed-epar-product-information_hu.pdf)

Malti (MT) (639.03 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/mt/documents/product-information/clopidogrel-qualimed-epar-product-information_mt.pdf)

Nederlands (NL) (464.05 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/nl/documents/product-information/clopidogrel-qualimed-epar-product-information_nl.pdf)

norsk (NO) (453.4 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/no/documents/product-information/clopidogrel-qualimed-epar-product-information_no.pdf)

polski (PL) (643.3 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/pl/documents/product-information/clopidogrel-qualimed-epar-product-information_pl.pdf)

português (PT) (529.59 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/pt/documents/product-information/clopidogrel-qualimed-epar-product-information_pt.pdf)

română (RO) (465.05 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/ro/documents/product-information/clopidogrel-qualimed-epar-product-information_ro.pdf)

slovenčina (SK) (640.28 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/sk/documents/product-information/clopidogrel-qualimed-epar-product-information_sk.pdf)

slovenščina (SL) (613.95 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/sl/documents/product-information/clopidogrel-qualimed-epar-product-information_sl.pdf)

Suomi (FI) (458.56 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/fi/documents/product-information/clopidogrel-qualimed-epar-product-information_fi.pdf)

svenska (SV) (459.92 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

08/09/2014

[View](/sv/documents/product-information/clopidogrel-qualimed-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0008 01/09/2014

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

## Product details

Name of medicine Clopidogrel Qualimed Active substance clopidogrel (as hydrochloride) International non-proprietary name (INN) or common name clopidogrel Therapeutic area (MeSH)

- Peripheral Vascular Diseases
- Stroke
- Myocardial Infarction

Anatomical therapeutic chemical (ATC) code B01AC06

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

Clopidogrel is indicated in adults for the prevention of atherothrombotic events in:

- Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

For further information please refer to section 5.1.

## Authorisation details

EMA product number EMEA/H/C/001135

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Qualimed

117 allée des Parcs

Marketing authorisation issued 23/09/2009 Withdrawal of marketing authorisation 01/09/2014 Revision 4

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Clopidogrel Qualimed : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (243.1 KB - PDF)

**First published:** 09/08/2010

**Last updated:** 08/09/2014

[View](/en/documents/procedural-steps-after/clopidogrel-qualimed-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Clopidogrel Qualimed : EPAR - Public assessment report

English (EN) (453.38 KB - PDF)

**First published:** 14/10/2009

**Last updated:** 08/09/2014

[View](/en/documents/assessment-report/clopidogrel-qualimed-epar-public-assessment-report_en.pdf)

**This page was last updated on** 08/09/2014

## Share this page

[Back to top](#main-content)